Respiratory Syncytial Virus Prophylaxis in Neurologic and Muscular Disorders in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab-Reference-Cited by-同舟云学术

Respiratory Syncytial Virus Prophylaxis in Neurologic and Muscular Disorders in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab

Published:2019-08 Issue:8 Volume:38 Page:775-780
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Wang Daniel Y.,Saleem Mahwesh,Paes Bosco A.,Mitchell Ian,Li Abby,Lanctôt Krista L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health

Reference41 articles.

1. Risk of primary infection and reinfection with respiratory syncytial virus.;Glezen;Am J Dis Child,1986

2. Respiratory syncytial virus–a comprehensive review.;Borchers;Clin Rev Allergy Immunol,2013

3. A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom.;Bentley;Health Econ Rev,2013

4. Defining the risk and associated morbidity and mortality of severe respiratory syncytial virus infection among infants with chronic lung disease.;Paes;Infect Dis Ther,2016

5. Defining the risk and associated morbidity and mortality of severe respiratory syncytial virus infection among preterm infants without chronic lung disease or congenital heart disease.;Figueras-Aloy;Infect Dis Ther,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection;Pediatrics;2023-06-26

2. Recent Advances in the Prevention of RSV in Neonates and Young Infants;Pediatric Infection & Vaccine;2023

3. Respiratory Syncytial Virus-Attributable Deaths in a Major Pediatric Hospital in New South Wales, Australia, 1998–2018;Pediatric Infectious Disease Journal;2021-11-26

4. Respiratory Syncytial Virus Immunoprophylaxis with Palivizumab: 12-Year Observational Study of Usage and Outcomes in Canada;American Journal of Perinatology;2021-03-03

5. Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries;Expert Review of Anti-infective Therapy;2020-12-08